Skip to main content
. 2021 Apr 15;10(2):217–225. doi: 10.1089/jayao.2020.0071

Table 2.

Logistic Regression for Odds of Insulin Prescription Within 1 Year of First Primary Invasive Cancer Diagnosis Among Adolescents and Young Adults: 2009–2019

Characteristic Adjusted model
Insulin prescription within 1 year of cancer diagnosis vs. no history of insulin prescription
OR (95% CI) p
BMI
 kg/m2, continuous 1.06 (1.02–1.11) 0.005
Age at cancer diagnosis
 Years, continuous 1.03 (0.96–1.11) 0.38
Sex
 Female 1.00 (—)  
 Male 1.78 (0.86–3.70) 0.12
Marital status
 Unmarried 1.00 (—)  
 Married 0.64 (0.30–1.40) 0.26
Smoking history
 Never smoker 1.00 (—)  
 Ever smoker* 0.89 (0.39–2.02) 0.78
Glucocorticoid prescription**
 No 1.00 (—)  
 Yes 1.00 (0.46–2.17) 0.99
Chemotherapy
 None/unknown 1.00 (—)  
 Yes 1.13 (0.52–2.48) 0.76
Surgery
 None/unknown 1.00 (—)  
 Yes 0.90 (0.24–3.38) 0.88
Hormone therapy
 None/unknown 1.00 (—)  
 Yes 0.54 (0.18–1.60) 0.26
Immunotherapy
 None/unknown 1.00 (—)  
 Yes 0.20 (0.03–1.55) 0.12
Radiation therapy
 None/unknown 1.00 (—)  
 Yes 1.80 (0.81–4.04) 0.15
*

Ever smoker includes current and former smokers.

**

First glucocorticoid prescription 1+ days after cancer diagnosis.

CI, confidence interval; OR, odds ratio.